Drugs / UFTE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01409005 | Jun 2011 → Feb 2013 | colorectal cancer | Seoul National University Bundang Hospital | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | UFTE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01409005 ↗ |
| Route | Oral | “UFTE : 200mg/m2 PO q 8 hr, Days 1\~21” NCT01409005 ↗ |